Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Nicotine exposure and tardive dyskinesia.

Yassa R, Lal S, Korpassy A, Ally J.

Biol Psychiatry. 1987 Jan;22(1):67-72.

PMID:
3790642
2.

Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial.

Diehl A, Reinhard I, Schmitt A, Mann K, Gattaz WF.

Eur Psychiatry. 2009 Jan;24(1):33-40. doi: 10.1016/j.eurpsy.2008.07.007. Epub 2008 Sep 6.

PMID:
18774276
3.

Hypothesis: a nicotine-dopamine interaction linking smoking with Parkinson's disease and tardive dyskinesia.

Kirch DG, Alho AM, Wyatt RJ.

Cell Mol Neurobiol. 1988 Sep;8(3):285-91. Review.

PMID:
3066487
4.

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients.

Steen VM, Løvlie R, MacEwan T, McCreadie RG.

Mol Psychiatry. 1997 Mar;2(2):139-45.

PMID:
9106238
5.

A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.

Basile VS, Ozdemir V, Masellis M, Walker ML, Meltzer HY, Lieberman JA, Potkin SG, Alva G, Kalow W, Macciardi FM, Kennedy JL.

Mol Psychiatry. 2000 Jul;5(4):410-7.

PMID:
10889552
6.

Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.

Chakos MH, Alvir JM, Woerner MG, Koreen A, Geisler S, Mayerhoff D, Sobel S, Kane JM, Borenstein M, Lieberman JA.

Arch Gen Psychiatry. 1996 Apr;53(4):313-9.

PMID:
8634009
7.

A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.

Ghadirian AM, Annable L, Bélanger MC, Chouinard G.

J Clin Psychiatry. 1996 Jan;57(1):22-8.

PMID:
8543543
8.

Handedness and the risk of tardive dyskinesia.

Morgenstern H, Glazer WM, Doucette JT.

Biol Psychiatry. 1996 Jul 1;40(1):35-42.

PMID:
8780853
9.

Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and tardive dyskinesia in schizophrenia.

Schulze TG, Schumacher J, Müller DJ, Krauss H, Alfter D, Maroldt A, Ahle G, Maroldt AO, Novo y Fernández A, Weber T, Held T, Propping P, Maier W, Nöthen MM, Rietschel M.

Am J Med Genet. 2001 Aug 8;105(6):498-501.

PMID:
11496364
10.

Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables.

Mukherjee S, Rosen AM, Cardenas C, Varia V, Olarte S.

Arch Gen Psychiatry. 1982 Apr;39(4):466-9.

PMID:
6121547
11.

Affective symptomatology in schizophrenia: a risk factor for tardive dyskinesia?

Schulze TG, Müller DJ, Krauss H, Marwinski K, Maroldt AO, Novo Y Fernández A, Fimmers R, Held T, Maier W, Nöthen MM, Rietschel M.

Eur Psychiatry. 2001 Feb;16(1):71-4.

PMID:
11246296
13.

Ethnicity and the course of tardive dyskinesia in outpatients presenting to the motor disorders clinic at the Maryland psychiatric research center.

Wonodi I, Adami HM, Cassady SL, Sherr JD, Avila MT, Thaker GK.

J Clin Psychopharmacol. 2004 Dec;24(6):592-8.

PMID:
15538119
14.

Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene.

Chong SA, Tan EC, Tan CH, Mythily.

J Psychiatry Neurosci. 2003 May;28(3):185-9.

15.

Tardive dyskinesia in northern Israel: preliminary study.

Schwartz M, Silver H, Tal I, Sharf B.

Eur Neurol. 1993;33(3):264-6.

PMID:
8096816
16.

Tardive dyskinesia.

Jeste DV, Caligiuri MP.

Schizophr Bull. 1993;19(2):303-15. Review.

PMID:
8100643
17.

Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients.

Bailey LG, Maxwell S, Brandabur MM.

Psychopharmacol Bull. 1997;33(1):177-81.

PMID:
9133772
18.

High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics.

Harris MJ, Panton D, Caligiuri MP, Krull AJ, Tran-Johnson TK, Jeste DV.

Psychopharmacol Bull. 1992;28(1):87-92.

PMID:
1609047
19.

Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.

Tiwari AK, Deshpande SN, Rao AR, Bhatia T, Mukit SR, Shriharsh V, Lerer B, Nimagaonkar VL, Thelma BK.

Pharmacogenomics J. 2005;5(1):60-9.

PMID:
15505641
20.

Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment.

Byne W, White L, Parella M, Adams R, Harvey PD, Davis KL.

Int J Geriatr Psychiatry. 1998 Jul;13(7):473-9.

PMID:
9695037

Supplemental Content

Support Center